Back to COGT

UBS Group AG → COGT

UBS Group AG COGT Position History

Cogent Biosciences, Inc. • Healthcare

Quarters held
13
Latest value
$320K
Q3 2026
Peak value
$53.2M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$26.6M
Q4 2025$9.3M
Q4 2025$61K
Q1 2026$370K
Q1 2026$10.8M
Q1 2026$58K
Q2 2026$384K
Q2 2026$42.9M
Q2 2026$164K
Q3 2026$67K
Q3 2026$53.2M
Q3 2026$195K
Q3 2026$320K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$320K10.0K——
Q3 2026$195K6.1K——
Q3 2026$53.2M1.66M——
Q3 2026$67K2.1K——
Q2 2026$164K4.2K——
Q2 2026$42.9M1.11M——
Q2 2026$384K9.9K——
Q1 2026$58K1.5K——
Q1 2026$10.8M280.4K——
Q1 2026$370K9.6K——
Q4 2025$61K1.7K——
Q4 2025$9.3M262.3K——
Q3 2025$26.6M1.85M——

Other funds holding COGT

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B